Psych Congress 2017

Early Diagnosis Can Improve Outcomes in Treatment-Resistant Schizophrenia

September 26, 2017

Different clinical and neurobiologic pathways may be involved in treatment-resistant schizophrenia as it is not a homogeneous subgroup within the schizophrenia spectrum.

Survey Shows Adult ADHD Often Goes Untreated

September 26, 2017

Results indicate there is an unmet need for better treatment to manage symptom burden in US adults with ADHD.

SHP465 MAS Found to Be Safe, Effective in Adult ADHD

By September 26, 2017

SHP465 MAS is a once-daily, extended-release oral agent for the treatment of ADHD that contains equal parts of 4 salts: dextroamphetamine sulfate, amphetamine sulfate, dextroamphetamine saccharate, and amphetamine aspartate monohydrate.

Strategies for Managing Treatment-Resistant MDD Explored

September 20, 2017

Augmentation therapy for treatment-resistant major depressive disorder includes multiple options with different strengths and limitations.

Significant Improvement in Schizophrenia Symptoms After Antipsychotic Injectable Switch

By September 19, 2017

The 6-month study examined the safety, efficacy, and tolerability of Aristada in patients with schizophrenia who had an inadequate response or intolerance to Invega Sustenna.

Antipsychotic Dose Reduction Outcomes Assessed in Bipolar Disorder, MDD Patients

September 19, 2017

For patients with bipolar disorder and major depressive disorder, reduction in dose of antipsychotic medication could lead to an increased rate of hospitalization.

Evidence-Based Autism Treatment Models Continue to Grow

September 19, 2017

Recent changes in our understanding of autism are driving advances in diagnosis, evidence-based treatment, and ultimately patient outcomes.

Disruptive Mood Dysregulation Disorder: New Tx Approach Investigated

September 18, 2017

Combination treatment may provide relief from the distinctive symptoms of severe, recurrent temper outbursts and persistent irritability.

For Obsessive Compulsive Disorder, SSRIs, CBT Found to Be Effective

September 18, 2017

Dr. Grant also acknowledged that while some patients are uncomfortable with the fact that medication doses for OCD are higher than they are for depression, those higher doses are crucial for symptomatic improvement.

Depression Tx Update: Managing Side Effects, Improving Efficacy

September 18, 2017

Michael Thase, MD, discusses therapy options as well as side effect management for individuals with major depressive disorder.

Review Assesses Pharmacotherapy Efficacy in Alcohol, Substance Abuse

September 18, 2017

New pharmacotherapies in combination with psychotherapy and counseling have proven effective in preventing relapse. Re